Endoscopic sleeve gastroplasty using the novel single-channel suturing device: A multicenter experience

Area of Science:

• Bariatric surgery
• Gastroenterology
• Medical devices

Background:

• Endoscopic sleeve gastroplasty (ESG) is a recognized treatment for obesity.
• A novel single-channel endoscopic suturing device has emerged, potentially simplifying ESG procedures.
• Limited data exists on the efficacy and safety of this new device for ESG.

Purpose of the Study:

• To evaluate the efficacy and safety of a novel single-channel endoscopic suturing device for ESG.
• To assess the technical feasibility and complication rates of ESG using this device.
• To determine the degree of total body weight loss achieved at one year post-procedure.

Main Methods:

• A multicenter retrospective study reviewed 18 patients who underwent ESG with the single-channel device.
• Procedures were performed between 2020-2021 utilizing a
• U
• suture pattern.
• Primary outcomes included technical success and safety; secondary outcome was 1-year total body weight loss.

Main Results:

• ESG was technically successful in 94% of patients (17/18).
• The average procedure time was 96.5 minutes, with an average of five sutures used.
• At 12 months, patients achieved a mean total body weight loss of 13.1%, with 56% losing over 15% of their body weight.

Conclusions:

• The single-channel endoscopic suturing system is a safe and effective tool for performing ESG.
• This device facilitates significant weight loss in patients with obesity at the one-year follow-up.
• The findings support the utility of this novel device in bariatric interventions.